IONS

SVB Securities analyst Mani Foroohar maintained a Hold rating on Ionis Pharmaceuticals (IONS - Research Report) today and set a price target of $26.00. The company's shares closed yesterday at $43.06.According to TipRanks, Foroohar is an analyst with an average return of -15.3% and a 37.80% success rate. Foroohar covers the Healthcare sector, focusing on stocks such as Rocket Pharmaceuticals, Moderna, and Alnylam Pharma.The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ionis Pharmaceuticals with a $51.17 average price target.See the top stocks recommended by analysts >>The company has a one-year high of $48.82 and a one-year low of $25.04.
https://www.tipranks.com/news/blurbs/svb-securities-sticks-to-their-hold-rating-for-ionis-pharmaceuticals-ions?utm_source=advfn.com&utm_medium=referral